Objective brain biomarkers from resting-state fMRI

Our platform analyzes whole-brain directional information flow from resting-state fMRI to support patient stratification, clinical trial endpoints, and treatment monitoring.

We are engaging with research and industry partners to evaluate translational use cases and explore early pilot collaborations.